AU4469201A - Novel crystal form of pyrrolidylthiocarbapenem derivative - Google Patents

Novel crystal form of pyrrolidylthiocarbapenem derivative

Info

Publication number
AU4469201A
AU4469201A AU4469201A AU4469201A AU4469201A AU 4469201 A AU4469201 A AU 4469201A AU 4469201 A AU4469201 A AU 4469201A AU 4469201 A AU4469201 A AU 4469201A AU 4469201 A AU4469201 A AU 4469201A
Authority
AU
Australia
Prior art keywords
novel crystal
crystal form
pyrrolidylthiocarbapenem derivative
pyrrolidylthiocarbapenem
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU4469201A
Other languages
English (en)
Inventor
Izumi Saitoh
Masayuki Takahira
Toshio Kawakita
Yasuyuki Yoshioka
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=18614158&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU4469201(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Publication of AU4469201A publication Critical patent/AU4469201A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
AU4469201A 2000-03-31 2001-03-30 Novel crystal form of pyrrolidylthiocarbapenem derivative Pending AU4469201A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000099868 2000-03-31
PCT/JP2001/002834 WO2001072750A1 (fr) 2000-03-31 2001-03-30 Nouvelle forme cristalline d'un derive de pyrrolidylthiocarbapenem

Publications (1)

Publication Number Publication Date
AU4469201A true AU4469201A (en) 2001-10-08

Family

ID=18614158

Family Applications (2)

Application Number Title Priority Date Filing Date
AU4469201A Pending AU4469201A (en) 2000-03-31 2001-03-30 Novel crystal form of pyrrolidylthiocarbapenem derivative
AU2001244692A Ceased AU2001244692B2 (en) 2000-03-31 2001-03-30 Novel crystal form of pyrrolidylthiocarbapenem derivative

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001244692A Ceased AU2001244692B2 (en) 2000-03-31 2001-03-30 Novel crystal form of pyrrolidylthiocarbapenem derivative

Country Status (17)

Country Link
US (5) US20030153191A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1270575B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JP3375084B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR100472842B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CN (1) CN1192030C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE304014T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (2) AU4469201A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BR (1) BRPI0109712B8 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2404703C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CY (2) CY1105674T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE60113243T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DK (1) DK1270575T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2252205T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
MX (1) MXPA02009592A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
TW (1) TWI293631B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2001072750A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA200207675B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02009592A (es) * 2000-03-31 2003-03-12 Shionogi & Co Nueva forma cristalina de derivado de pirrolidiltiocarbapenema.
JP5004355B2 (ja) * 2001-05-10 2012-08-22 塩野義製薬株式会社 アセチルチオピロリジン誘導体の製法
EA200400682A1 (ru) * 2001-11-16 2004-10-28 Рэнбакси Лабораториз Лимитед Способ получения кристаллического имипенема
TWI353855B (en) 2005-05-26 2011-12-11 Shionogi & Co Method for preparing an aqueous solution of doripe
JP5671204B2 (ja) * 2006-04-28 2015-02-18 株式会社カネカ カルバペネム抗生物質中間体の改良された晶析方法
WO2008006298A1 (fr) * 2006-07-03 2008-01-17 Chengdu Di'ao Jiuhong Pharmaceutical Factory Nouvelle forme cristalline de doripenem, préparation, procédé et utilisations de celle-ci
CN101191787B (zh) * 2006-11-21 2011-07-27 上海医药工业研究院 高效液相色谱法测定多利培南含量的方法
US8445673B2 (en) * 2008-03-24 2013-05-21 Ranbaxy Laboratories Limited Process for the preparation of sterile doripenem
CN103025733B (zh) * 2010-06-03 2015-11-25 山东轩竹医药科技有限公司 碳青霉烯类衍生物或其水合物的晶型及其制备方法与用途
CN102977101A (zh) * 2011-09-07 2013-03-20 中国人民解放军军事医学科学院毒物药物研究所 多尼培南一水合物、其药物组合物、其制备方法和用途
CN102285988B (zh) * 2011-09-08 2012-09-05 上海希迈医药科技有限公司 一种多尼培南水合物晶体及其制备方法
EP2776440A1 (en) * 2011-11-08 2014-09-17 Ranbaxy Laboratories Limited Process for the preparation of polymorphs of doripenem
CN104072497B (zh) * 2013-03-29 2017-10-03 石药集团中奇制药技术（石家庄）有限公司 一种多尼培南新结晶及其制备方法
CN103389347B (zh) * 2013-07-26 2015-12-09 深圳市海滨制药有限公司 高效液相色谱法测定多尼培南的方法
JP6477728B2 (ja) * 2014-04-28 2019-03-06 ジェイダブリュ ファーマセウティカル コーポレーション ドリペネムの新規な結晶およびその製造方法
KR20160007679A (ko) 2016-01-04 2016-01-20 제일약품주식회사 도리페넴의 신규한 결정형

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5317016A (en) * 1991-08-20 1994-05-31 Shionogi Seiyaku Kabushiki Kaisha Pyrrolidylthiocarbapenem derivative
US5539102A (en) * 1992-02-21 1996-07-23 Shionogi Seiyaku Kabushiki Kaisha Production method for sulfamide
DE69528166T2 (de) * 1994-05-02 2003-04-30 Shionogi & Co., Ltd. Kristalline pyrrolidylthiocarbapenem derivate, lyophilisierste präparationen dieser kristalle und verfahren zu deren herstellung
JP3558684B2 (ja) * 1994-06-28 2004-08-25 塩野義製薬株式会社 ピロリジルチオカルバペネム誘導体の乾燥方法
MXPA02009592A (es) * 2000-03-31 2003-03-12 Shionogi & Co Nueva forma cristalina de derivado de pirrolidiltiocarbapenema.
EP1595883A4 (en) * 2003-02-14 2008-11-26 Shionogi & Co INTERMEDIATE PRODUCT CRYSTAL FOR CARBAPENEM
US20120035357A1 (en) 2009-02-26 2012-02-09 Orchid Chemicals & Pharmaceuticals Ltd. Process for the preparation of carbapenem antibiotic

Also Published As

Publication number Publication date
US20030153191A1 (en) 2003-08-14
CY2009001I2 (el) 2009-11-04
ATE304014T1 (de) 2005-09-15
BR0109712A (pt) 2003-04-29
US20080207586A1 (en) 2008-08-28
JP3375084B2 (ja) 2003-02-10
US9221823B2 (en) 2015-12-29
CA2404703C (en) 2007-06-05
DE60113243D1 (de) 2005-10-13
US20150031664A1 (en) 2015-01-29
ZA200207675B (en) 2003-09-25
EP1270575A1 (en) 2003-01-02
EP1270575A4 (en) 2004-02-18
ES2252205T3 (es) 2006-05-16
DE60113243T2 (de) 2006-02-16
CN1192030C (zh) 2005-03-09
CN1432016A (zh) 2003-07-23
KR100472842B1 (ko) 2005-03-10
CY1105674T1 (el) 2010-07-28
US8247402B2 (en) 2012-08-21
WO2001072750A1 (fr) 2001-10-04
TWI293631B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2008-02-21
US20070060562A1 (en) 2007-03-15
BRPI0109712B8 (pt) 2021-05-25
BRPI0109712B1 (pt) 2017-10-24
EP1270575B1 (en) 2005-09-07
AU2001244692B2 (en) 2004-10-14
DK1270575T3 (da) 2006-01-16
MXPA02009592A (es) 2003-03-12
CA2404703A1 (en) 2002-09-26
US20130059831A1 (en) 2013-03-07
KR20020087446A (ko) 2002-11-22
CY2009001I1 (el) 2009-11-04

Similar Documents

Publication Publication Date Title
AU4469201A (en) Novel crystal form of pyrrolidylthiocarbapenem derivative
IL157773A0 (en) 2-amino-propanol derivatives
CA2442219A1 (en) Enantioselective synthesis of azetidinone intermediate compounds
AP2002002637A0 (en) Novel piperazine
CA2368347A1 (en) Glucokinase activators
CA2445306A1 (en) Process for preparing 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
CA2150123A1 (en) Aminomethylene substituted non-aromatic heterocycles
EP1783113A3 (en) Crystal form VII of atorvastatin hemi-calcium
MA23257A1 (fr) Nouvelle forme de compose demagnesium d'omeprazole etson utilisation .
AU2003297291A1 (en) Substituted arylcyclopropylacetamides as glucokinase activators
AU2003278592A1 (en) A novel crystalline form of linezolid
AU673893B2 (en) New pyridothiadiazones, processes for their preparation and the pharmaceutical compositions which contain them
CA2043709A1 (en) Antimigraine alkoxypyrimidine derivatives
IL123078A0 (en) Pharmaceutical compositions containing carbapenem and their preparation
IE851623L (en) Substituted benzamides
CA2505968A1 (en) Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
HK72592A (en) Substituted benzamide
DE60311516D1 (en) Perindopril
CA2125549A1 (en) Tetrazole derivatives, their production and use
GR3033350T3 (en) Use of Beta-aminopropionic acid derivatives as fungicides
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
HRP931309A2 (en) New substituted azetidinones as anti-inflammatory and antidegenerative agents
AU2002245005A1 (en) Thiazolopyrimidine derivatives and use thereof as antagonists of the cx3 cr1 receptor
CA2427762A1 (en) Process for the preparation of crystalline n-formimidoyl thienamycin monohydrate (imipenem monohydrate)
CA2127374A1 (fr) Nouveau derive de l'isoindolinone, sa preparation et les compositions pharmaceutiques qui le contiennent